| Identification | |
| Name: | Ranitidine |
| Synonyms: | Midaven;Zenetac;1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-;Acidex; |
| CAS: | 66357-35-5 |
| EINECS: | 266-332-5 |
| Molecular Formula: | C13H22N4O3S |
| Molecular Weight: | 350.87 |
| InChI: | InChI=1/C13H22N4O3S/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3/b13-9+ |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.184 g/cm3 |
| Stability: | No data. |
| Refractive index: | 1.558 |
| Water Solubility: | 24.7 mg/mL |
| Solubility: | 24.7 mg/mL in water |
| Appearance: | White powder |
| Specification: |
?Ranitidine?(CAS NO.66357-35-5) is also called as 1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro- ;?MeSH Heading ;?Ranitidine ; Ranitidine [USAN:INN:BAN] ; 1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro- ; Achedos ; Acidex ; Atural ; Axoban ; Coralen ; Curan ; Duractin ; Ezopta ; Gastrial ; Gastrosedol ; Istomar ; Logast ; Major ranitidine ; Mauran ; Microtid ; N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine ; Ptinolin ; Quantor ; Quicran ; RND ; Radinat ; Randin ; Ranidine ; Ranin ; Raniogas?; Ranisen ; Raniter ; Ranitidina ; Ranitidina [INN-Spanish] ; Ranitidinum [INN-Latin] ; Ranitiget ; Rantacid ; Ratic ; Raticina ; Sampep ; Taural ; Ul-Pep ; Ulceranin ; Urantac ; Verlost ; Vesyca ; Vizerul ; Weichilin ; Weidos ; Xanidine ; Zantab ; Zantadin . |
| Biological Activity: | Potent, selective and competitive histamine H 2 receptor antagonist (pA 2 = 6.95-7.2). In vivo, inhibits gastric acid secretion induced by histamine, pentagastrin, bethanecol and food. Also inhibits aspirin-induced gastric lesions. |
| Storage Temperature: | Ranitidine hydrochloride tablets or solution should be stored in a dry place at 15-30C in tight, light-resistant containers. |
| Color: | tan |
| Usage: | Medication. |
| Safety Data | |
 |
|
